r/pennystocks
🎩✅CVRX - The strategic value of Barostim could be significantly higher than the current valuation
- upvotes
- 2
- comments
- 2
Post
A few facts that are difficult to ignore right now: • CVRx reported **$15.7M in Q2 2026 revenue**, up 16% YoY, with an **87% gross margin**. U.S. revenue grew 21%. • In May, **Humana** introduced Medicare Advantage coverage for Barostim. Today, CVRx announced that **Devoted Health** also issued a coverage policy, effective July 17, 2026. Together, Humana and Devoted represent approximately **21% of Medicare Advantage enrollment**. Devoted covers approximately **466,000 members across 29 states**, including patients enrolled in BENEFIT-HF. • At the Canaccord conference, CEO Kevin Hykes discussed **5–7 strategic companies** for which Barostim could fit very naturally into their existing portfolios. This does **not** mean those companies are currently making offers, but it does show that management sees meaningful strategic value in the technology. • And now the most interesting development: shareholder **Jorey Chernett**, who owns more than **5.5% of CVRx**, has called on the Board to immediately retain an independent financial advisor and begin a strategic alternatives process, with a **sale of the company to a strategic buyer as the priority outcome**. In my view, the four most logical strategic buyers are: ✅**Johnson & Johnson, Boston Scientific, Medtronic and Abbott.** This is based on strategic fit - **not** an assertion that any of them are currently in...
Keep reading with a free account
The rest of this post, and every signal for Humana, is in your free account.
Extracted from these lines
In May, Humana introduced Medicare Advantage coverage for Barostim.
From the post
Together, Humana and Devoted represent approximately 21% of Medicare Advantage enrollment.
From the post